Health
Diabetes drug can treat and reverse heart failure and reduce – EurekAlert
Mount Sinai clinical trial results could help lead to FDA approval
Empagliflozin, a recently developed diabetes drug, can effectively treat and reverse heart failure in both diabetic and non-diabetic patients, according to researchers at the Icahn School of Medicine at Mount Sinai.
Their clinical trial showed that this medication can improve the heart’s size, shape, and function, leading to better exercise capacity and quality of life, which will reduce hospitalizations for heart failure patients. The results were presented on Friday, November 13, at the American…
-
Noosa News22 hours ago‘Just want to know he’s safe’: Family’s German Shepherd asleep in back of stolen ute
-
Noosa News22 hours agoDriver acquitted of murder over lengthy road-rage chase
-
Business23 hours agoEverything you need to know about the latest ANZ dividend
-
General20 hours agoMitchell Starc fires Ashes warning in Sheffield Shield return as Jake Weatherald and Beau Webster fail to fire